Cilnidipine

西尼地平

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCilnidipine
Drug Alias NamecilnidipinumAtelecCinalongSiscardFRC-8653 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsHypertensionStroke
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryJapan
Original Approved Date1995/01/01
Country/TerritorySouth KoreaMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMochda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEa PharmaMochda Pharmaceutical Co LtdBengbu Fengyuan Pharmaceutical Co Ltd
Inactive CompaniesBoryung Pharmaceutical Co Ltd
Active IndicationsHypertension
Inactive IndicationsStroke

Other Information

ATC CodeC08CA14
Related LinksWikipediaDrugBankKEGG